XML 19 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation (Details Textual)
9 Months Ended
Sep. 30, 2015
$ / shares
shares
Other information  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares 248,919
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 7.32
Phantom Stock [Member]  
Other information  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value $ 29.57
Stock Issued During Period, Shares, Issued for Services | shares 3,804
Total Shareholder Return [Member]  
Weighted-Average Grant Date Fair Value  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 47.24
Return On Invested Capital [Member]  
Weighted-Average Grant Date Fair Value  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value 30.16
Restricted Stock [Member]  
Weighted-Average Grant Date Fair Value  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 30.00
Other information  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 74,375
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares 82,959
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 21.80
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 3 years
Performance awards [Member]  
Other information  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 69,978